Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsReceivables RefundsShares Issued
Ratios

Ligand Pharmaceuticals (LGND) Long-Term Debt Issuances (2019 - 2022)

Historic Long-Term Debt Issuances for Ligand Pharmaceuticals (LGND) over the last 5 years, with Q3 2022 value amounting to $202000.0.

  • Ligand Pharmaceuticals' Long-Term Debt Issuances fell 9030.24% to $202000.0 in Q3 2022 from the same period last year, while for Dec 2024 it was $202000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $202000.0 for FY2022, which is 9893.34% down from last year.
  • As of Q3 2022, Ligand Pharmaceuticals' Long-Term Debt Issuances stood at $202000.0, which was down 9030.24% from $2.1 million recorded in Q3 2021.
  • In the past 5 years, Ligand Pharmaceuticals' Long-Term Debt Issuances ranged from a high of $16.9 million in Q1 2021 and a low of $202000.0 during Q3 2022
  • Over the past 3 years, Ligand Pharmaceuticals' median Long-Term Debt Issuances value was $7.2 million (recorded in 2019), while the average stood at $7.9 million.
  • Over the last 5 years, Ligand Pharmaceuticals' Long-Term Debt Issuances had its largest YoY gain of 9030.24% in 2022, and its largest YoY loss of 9030.24% in 2022.
  • Over the past 3 years, Ligand Pharmaceuticals' Long-Term Debt Issuances (Quarter) stood at $12.4 million in 2019, then plummeted by 83.2% to $2.1 million in 2021, then crashed by 90.3% to $202000.0 in 2022.
  • Its Long-Term Debt Issuances stands at $202000.0 for Q3 2022, versus $2.1 million for Q3 2021 and $16.9 million for Q1 2021.